Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives. We are developing orally administered products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies.
Aquestive is committed to conducting our business with the highest ethical standards. The Company's commitment to ethics and good corporate citizenship is grounded in our compliance with laws and regulations that govern the way we do business.
Our policies are continually evolving to include updates and changes to laws, regulations, and codes impacting the pharmaceutical industry, as well as to incorporate internal policy improvements.